For: | Guo CX, Huang X, Xu J, Zhang XZ, Shen YN, Liang TB, Bai XL. Combined targeted therapy and immunotherapy for cancer treatment. World J Clin Cases 2021; 9(26): 7643-7652 [PMID: 34621816 DOI: 10.12998/wjcc.v9.i26.7643] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i26/7643.htm |
Number | Citing Articles |
1 |
Si-Cong Chen, Dong-Heng Ma, Jia-Jian Zhong. Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report. World Journal of Clinical Cases 2023; 11(27): 6579-6586 doi: 10.12998/wjcc.v11.i27.6579
Abstract(576) |
Core Tip(409) |
Full Article(HTML)(1054)
|
Full Article with Cover (PDF)-19348K(135)
|
Full Article (Word)-1830K(21)
|
Audio-348K(2)
|
Peer-Review Report-223K(51)
|
Answering Reviewers-333K(48)
|
Full Article (PDF)-19049K(79)
|
Full Article (XML)-59K(48)
|
Times Cited (0)
|
Total Visits (3662)
|
Open
|
2 |
Giandomenico Roviello, Melissa Bersanelli, Martina Catalano. The Latest Developments in Biomarkers Predicting Response to Immunotherapy. Immunotherapy 2022; 14(14): 1085 doi: 10.2217/imt-2022-0053
|
3 |
Fatemah S. Basingab, Manar Bashanfer, Aisha A. Alrofaidi, Ahmed S. Barefah, Rawan Hammad, Hadil M. Alahdal, Jehan S. Alrahimi, Kawther A. Zaher, Sabah Hassan, Ali H. Algiraigri, Mai M. El-Daly, Saleh A. Alkarim, Alia M. Aldahlawi. T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences 2024; 25(20): 11148 doi: 10.3390/ijms252011148
|
4 |
Lisa Schlicher, Luke G. Green, Andrea Romagnani, Florian Renner. Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1297175
|
5 |
Kiran Kumar Kolathur, Radhakanta Nag, Prathvi V Shenoy, Yagya Malik, Sai Manasa Varanasi, Ramcharan Singh Angom, Debabrata Mukhopadhyay. Molecular Susceptibility and Treatment Challenges in Melanoma. Cells 2024; 13(16): 1383 doi: 10.3390/cells13161383
|
6 |
Mariana Neves Amaral, Pedro Faísca, Hugo Alexandre Ferreira, Maria Manuela Gaspar, Catarina Pinto Reis. Current Insights and Progress in the Clinical Management of Head and Neck Cancer. Cancers 2022; 14(24): 6079 doi: 10.3390/cancers14246079
|
7 |
Sai Manasa Varanasi, Yash Gulani, Hari Krishnareddy Rachamala, Debabrata Mukhopadhyay, Ramcharan Singh Angom. Neuropilin-1: A Multifaceted Target for Cancer Therapy. Current Oncology 2025; 32(4): 203 doi: 10.3390/curroncol32040203
|
8 |
Yong-Po Zhang, Yue-Wei Tian, Jiang Geng, Xin-Hui Zhou, Meng-Ze Li, Guang-Huan Liu, Chun-Yan Gao, Ai-Qin Yue, Jin-Zhong Zhao, Wei-Jun Du. Nattokinase enhances the sensitivity of cancer cells to oxaliplatin through mitochondrial pathway and induction of apoptosis. Arabian Journal of Chemistry 2024; 17(1): 105478 doi: 10.1016/j.arabjc.2023.105478
|
9 |
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, Ghadeer Hussien, Rahaf Ahmed, Walaa Mousa, Ghalia Khoder, Mostafa Khair. Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy. Biomedicines 2024; 12(9): 2158 doi: 10.3390/biomedicines12092158
|
10 |
Xiaoya Guan, Huina Guo, Yujia Guo, Qi Han, Zhongxun Li, Chunming Zhang. Perforin 1 in Cancer: Mechanisms, Therapy, and Outlook. Biomolecules 2024; 14(8): 910 doi: 10.3390/biom14080910
|
11 |
Pankaj Garg, Siddhika Pareek, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment. Journal of Clinical Medicine 2024; 13(21): 6537 doi: 10.3390/jcm13216537
|
12 |
Lingyu Li, Yingli Sun. Challenges and advances of immune checkpoint therapy. Clinical and Translational Discovery 2024; 4(6) doi: 10.1002/ctd2.70001
|
13 |
Poulami Sarkar, Manami Sardar, Olivia Sen, Stabak Das, Sreejan Manna. Therapeutic Efficacy of Nanocarrier‐Mediated Inhalable Gene Transfection for Lung Cancer. ChemistrySelect 2024; 9(37) doi: 10.1002/slct.202402903
|